Obsidian Therapeutics logo

Obsidian Therapeutics

At Obsidian, our vision is pioneering engineered cell & gene therapies to deliver transformative outcomes for patients.

107 employees · est. 2015 · Cambridge, United States

VS
STRM.BIO logo

STRM.BIO

Fulfilling the promise of gene therapy.

14 employees · est. 2019 · Boston, United States

Obsidian Therapeutics is the older company (2015 vs 2019); Obsidian Therapeutics is the larger of the two.

Side-by-Side Comparison

Obsidian Therapeutics STRM.BIO
Founded
2015 older 2019
Headquarters
Cambridge, United States Boston, United States
Employees
107 larger 14
Industry
Biotechnology, Health Care, Pharmaceutical Biotechnology
Funding Stage
Unknown Grant
Total Funding
$675.00M $2.10M
Funding Rounds
4 3
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Cell Therapy, Gene Therapy, Controllable Therapies, CytoDrive Technology, Transformative Outcomes, Intractable Diseases, Clinical Need, Cambridge, Bedford, Diverse Team, Inclusion, Employee Ownership, Clinical Efficacy, Investor-backed Gene Therapy, Extracellular Vesicles, EVs, Pre-clinical, VC-backed, Boston, Therapeutics, Rare Diseases, In Vivo, Nucleic Acids, Proteins, Targeting Capabilities, Immunogenicity, Commercial Manufacture
Website
obsidiantx.com strm.bio
Obsidian Therapeutics logo

About Obsidian Therapeutics

Obsidian Therapeutics, founded in 2015, is a **biotechnology** startup based in the United States, with a recent Series B investment of $115.00M on 09 September 2021. The company's focus lies in pioneering controllable cell and gene therapies to provide breakthrough solutions for patients suffering...

STRM.BIO logo

About STRM.BIO

STRM.BIO is a Boston-based biotechnology startup founded in 2019, with a goal to revolutionize gene therapy using extracellular vesicles (EVs). Backed by venture capital, notably including a grant investment from the Bill & Melinda Gates Foundation in October 2023, this pre-clinical company is dedic...

We will tell you when either one moves

BounceWatch watches Obsidian Therapeutics and STRM.BIO for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Obsidian Therapeutics and STRM.BIO — by email.

Frequently Asked Questions

Obsidian Therapeutics — At Obsidian, our vision is pioneering engineered cell & gene therapies to deliver transformative outcomes for patients.. STRM.BIO — Fulfilling the promise of gene therapy.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Obsidian Therapeutics has raised $675.00M while STRM.BIO has raised $2.10M.
Obsidian Therapeutics and STRM.BIO operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Obsidian Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Obsidian Therapeutics on 9 Jun 2026, and STRM.BIO on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy